Insider Selling: Cantel Medical Corp. Director Sells 4,875 Shares of Stock (CMN)
Cantel Medical Corp. (NYSE:CMN) Director Ann Berman sold 4,875 shares of the company’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $32.21, for a total transaction of $157,023.75. Following the completion of the sale, the director now directly owns 13,097 shares in the company, valued at approximately $421,854. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Cantel Medical Corp. (NYSE:CMN) traded down 0.77% during mid-day trading on Tuesday, hitting $32.12. 114,854 shares of the company’s stock traded hands. Cantel Medical Corp. has a 52-week low of $16.1133 and a 52-week high of $32.72. The stock’s 50-day moving average is $28.0 and its 200-day moving average is $24.26. The company has a market cap of $1.302 billion and a P/E ratio of 34.07.
Cantel Medical Corp. (NYSE:CMN) last posted its quarterly earnings results on Thursday, September 26th. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.23 by $0.02. The company had revenue of $113.97 million for the quarter, compared to the consensus estimate of $105.75 million. During the same quarter in the prior year, the company posted $0.31 earnings per share. The company’s quarterly revenue was up 15.4% on a year-over-year basis. Analysts expect that Cantel Medical Corp. will post $1.03 EPS for the current fiscal year.
Cantel Medical Corp (NYSE:CMN) is a provider of infection prevention and control products and services in the healthcare market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.